Latest Doherty Institute News | Page 2

Burnet research honoured at AIDS 2022
Decade Long Plan For Home Grown Medical Research To Thrive
Rapid Antigen Test cancellations not due to failure to detect Covid Omicron variant
By June 2022, almost half of adult Australian population is estimated to have had Covid
National antibody study: By June, almost half of Aussies had recently had Covid
Combating drug-resistant bacteria
Mapping ‘energy fingerprints’ of lung cancer leads to fundamental treatment rethink
National antibody study confirms Covid cases higher than reported
How Covid created dramatic changes in ‘winter virus’
Volunteers receive first dose in clinical trial of Melbourne-made Covid vaccines
More natural air ventilation systems for NSW schools
New Fellowship To Continue Fight Against Infectious Diseases
Why Sentinel Cells are so Important
Recruitment commences for Phase 1 clinical trial of two Melbourne-made Covid vaccines
Doherty Institute secures landmark agreement with Moderna to expedite vaccine research for infectious diseases
Vaccine-induced T cells provide long-lasting immune response to Covid: study
How many Australians have had Covid?
Blood Donors Sought For New Covid Research Biobank
Covid clinical trials disproportionately run out of high-income countries research shows
Cannibal immune cells could offer new treatment path
Protecting remote communities in Northern Territory from Covid 2 February
Researchers discover way to disarm potentially deadly Listeria bacteria
Researchers discover new approach to breaking bacterial antibiotic resistance and rescue frontline drug treatments
Researchers discover new approach to breaking bacterial antibiotic resistance and rescue frontline drug treatments
Spleen function discovery could lead to better treatments for infectious diseases
T cells fit to tackle Omicron, suggests new study
Nasal spray to fight Covid heads to clinical trial
Burnet and Doherty scientists develop highly accurate point-of-care neutralising antibodies test for Covid
Protecting remote communities in Northern Territory from Covid 21 December
Jab Gab – where scientists discuss Covid vaccines, with unlikely help of comedians
Minister updated on research into Omicron variant, AIID Foundation Partners Agreement signed
Infectious Disease Institute Partners Set New Foundation
Step forward for AIID
Victoria to become home of mRNA vaccine manufacturing
Victoria recognises sustained excellence and early-career potential among science and innovation leaders
National Cabinet Statement 10 December
Clinical trial to examine whether ‘mixing’ Covid vaccine boosters is more effective
Health, business and aid leaders call on PM to ramp up global vax efforts amid Omicron warning shot
Call for action on global Covid vaccines
National recognition for NT testing program
Successful manufacture of Monash’s Covid mRNA vaccine candidate
Victoria produces Australia’s first mRNA Covid vaccine candidate
Victoria Makes Australia’s First mRNA Vaccine Candidate
No time to repeat mistakes of past
Honouring Our Rising Stars In Health And Medical Research
Removing disruptions for schools and families
Retail risk reduced by millions under proposed changes to NSW workers compensation laws
New analysis predicts how well vaccines will work against COVID19 strains